LRMR icon

Larimar Therapeutics

116 hedge funds and large institutions have $245M invested in Larimar Therapeutics in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 32 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

19% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 27

42% less capital invested

Capital invested by funds: $421M → $245M (-$176M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
116
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.13M
Puts
$400K
Net Calls
Net Calls Change

Top Buyers

1 +$3.39M
2 +$1.88M
3 +$1.54M
4
BlackRock
BlackRock
New York
+$1.13M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.06M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$5.8K
102
$5.19K
103
$4.55K
104
$4.13K
105
$3K
106
$3K
107
$2.79K
108
$1.57K
109
$464
110
$457
111
$166
112
$135
113
$55
114
$31
115
$15
116
117
118
119
120
121
122
123
124
125